Filter
651 - 660 of 1172 results
Results for
Adapting Malaria Services to Crises
Impact Brief
PMI VectorLink works with local partners to deliver crucial malaria services during crises like conflict.
Three Tips for Supporting Family Planning and the Private Sector
Impact Brief
Data analysis fueled a health financing model from USAID’s Abt-led SHOPS Plus, which demonstrates how pharmacies and drug shops can support family planning.
Defeating TB: Private Sector to Predictive Analytics
Podcast
How do we defeat tuberculosis? With sustainable solutions. With support from the private sector. With data.
Trust and Localization: The Missing Tools in Pandemic Preparedness and Response
News
What is humanity’s best defense against a pandemic or other major threat? You’d be partially right to think: high-tech equipment in gleaming new health facilities, a computer farm in the cloud to collect and share data, highly qualified clinical staff, vast sums for vaccine research and development, and expansive budgets funding expensive national public health systems.
Studies Show the Screening, Brief Intervention, and Referral to Treatment Approach to Prevention of Substance Use Disorders Works for Adolescents
News
The screening, brief intervention, and referral for treatment approach reduces substance misuse and improves education and employment outcomes for youths.
SSA and Abt Release Volume on Lessons From 30 Years of Demonstration Projects
News
The Social Security Administration and Abt released a book summarizing lessons from demonstration projects to improve outcomes for disability beneficiaries.
Abt to Identify Insights from Multi-Year Pregnancy Assistance Fund Grants
News
Abt Global Awarded Contract to Prevent Malaria through Vector Control
News
The U.S. Agency for International Development (USAID) has awarded Abt Global a global five-year, $809 million contract to prevent malaria.
Multiple COVID-19 Vaccine Doses Reduce Symptoms, Length of Illness, and Need for Medical Care
News
A study of essential and frontline workers with COVID-19 showed that two or three vaccine doses reduced symptoms, missed work, and the need for medical care.